Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0920646 (
renal ischemia
)
2,515
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Intravenous doses of 92.6 and 185.2 mumol S-(1,2-dichlorovinyl)-D-cysteine (D-
DCVC
)/kg were acutely nephrotoxic in pentobarbital-anesthetized dogs. During the 6-h period following administration of either dose, renal arterial blood flow decreased modestly, urinary excretion rate of protein increased, and in contrast to findings in rabbits, ultrastructural lesions developed only in S1 and S2 cells of proximal tubules. The higher dose also induced significant increases in urine flow rate and urinary excretion rate of glucose. The adverse changes noted following the low dose of D-
DCVC
were due to its direct renal actions and not to extrarenal actions such as major changes in blood gases, total renal blood flow or mean arterial blood pressure that could have indirectly contributed to renal damage via induction of episodes of
renal ischemia
or hypoxia. In addition, there was a correlation between the proximal tubular cell types injured by D-
DCVC
and the location of D-amino acid oxidase (DAAO) in the canine nephron. Overall, the nephrotoxicity of D-
DCVC
was characterized by the same renal function and ultrastructure changes as noted previously with L-
DCVC
, but the D-isomer was slightly less potent. Our data suggested that the similarity in the toxicity of D- and L-
DCVC
might be related to DAAO-catalyzed conversion of D-
DCVC
to the corresponding alpha-ketoacid (DCV-O-MPA) and subsequent biotransformation of the latter to the same highly reactive fragment as generated from the L-isomer.
...
PMID:Acute effects of the D-isomer of S-(1,2-dichlorovinyl)cysteine on renal function and ultrastructure in the pentobarbital-anesthetized dog: site-specific toxicity involving the S1 and S2 cells of the proximal tubule. 194 44